Jaundice resident survival guide
Jaundice Resident Survival Guide |
---|
Overview |
Causes |
Diagnosis |
Treatment |
Do's |
Don'ts |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Roghayeh Marandi, M.D.[2]
Synonyms and keywords: Approach to jaundice, Jaundice workup, Jaundice management
Overview
The classic definition of Jaundice is a serum bilirubin level higher than 2.5 to 3 mg per dL (42.8 to 51.3 μper L) in conjunction with a clinical picture of yellow skin and sclera. The causes of jaundice can be classified under these categories by measuring total bilirubin and its conjugated and unconjugated levels determine where is the dysfunction of bilirubin metabolism.
Causes
Life Threatening Causes
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
- Ascending cholangitis
- Sepsis
- Acute liver failure (the combination of jaundice with hepatic encephalopathy)
Common Causes
Common causes of acute Jaundice[1]
- Gilbert syndrome
- Alcoholic hepatitis
- Viral hepatitis
- Obstructive Jaundice due to choledocholithiasis or malignancy
- Decompensated chronic liver disease
Common causes of chronic progressive jaundice
Diagnosis
Shown below is an algorithm summarizing the diagnosis of jaundice.[2][3][4][5]
Characterize the jaundice duration and frequency ❑ Duration: short versus long ❑ Frequency: episodic vesus constant | |||||||||||||||||||||||||||||||||||||||||||||||
Ask about associated symptoms ❑ Abdominal pain (episodic or constant) ❑ Abdominal distension ❑ Fever ❑ Clay colored stool ❑ Dark urine ❑ Weight gain or loss ❑ Anorexia ❑ Dyspepsia ❑ Arthralgia ❑ Myalgia ❑ Back pain ❑ Rash ❑ Confusion | |||||||||||||||||||||||||||||||||||||||||||||||
Inquire about ❑ Past medical history ❑ Blood disorder
❑ Family history of ❑ Medication history
❑ Recent travel history
| |||||||||||||||||||||||||||||||||||||||||||||||
Examine the patient General Appearance ❑ Check for:
Skin exam
Cardiac exam
❑ Check gallbladder area if it is tender
❑ Splenomegaly can be seen in hemolytic states, Hodgkin’s lymphoma, portal hypertension
| |||||||||||||||||||||||||||||||||||||||||||||||
Order ❑ Blood tests
❑ Urine
| |||||||||||||||||||||||||||||||||||||||||||||||
Isolated unconjugated hyperbilirubinemia | Isolated conjugated hyperbilirubinemia | Unconjugated & conjugated hyperbilirubinemia | |||||||||||||||||||||||||||||||||||||||||||||
❑ Inquire about any recent trauma hematoma blood transfusion | ❑ Dubin-Johnson syndrome ❑ Rotor syndrome | ||||||||||||||||||||||||||||||||||||||||||||||
If none of them | With Liver enzyme changes | with ↑ INR,↓ Albumin,↓ Platelet | |||||||||||||||||||||||||||||||||||||||||||||
❑ Check Hb,LDH,Haptoglobin,Recticulocyte count | If ⇈AST/ALT out of proportion to ALK-P | If ⇈Alk-P out of proportion to AST/ALT | Suggestive of cCirrhosis Additional tests to find the cause of cirrhosis Hepatitis serology Iron panel Abdominal Ultrasound Workup for Automimmune hepatitis, NAFLD,Hemochromatosis & other causes of cirrhosis | ||||||||||||||||||||||||||||||||||||||||||||
Abnormal | Normal | Hepatocellular pattern | Cholestatic pattern | ||||||||||||||||||||||||||||||||||||||||||||
Start workup of hemolytic anemia with blood smear & coombs test | ❑ Gilbert syndrome ❑ Crigler-Najjar type I,II | Additional work-up for specific diseases Viral hepatitis serology(e.g. HAV,HBV,HCV) Toxicology screen Acetaminophen level Cereuloplasmin if patient<40 years of age Autoantibodies (ANA,Anti-sm,LKM,...) Ferritin & TIBC HbA1c Pregnancy test a1-antitrypsin ❑Consider work-up for rare cases Liver biopsy if results negative | Ultrasound | ||||||||||||||||||||||||||||||||||||||||||||
Consider following based on the results: ❑ Sickle cell disease ❑ Hereditary spherocytosis ❑ G6PD deficiency ❑ Medications effect( Rifampicin, Probencid) ❑ Immune-mediated hemolysis | Consider following based on the results: ❑ Viral hepatitis ❑ NAFLD (Non-alcoholic liver disease) ❑ ppAlcoholic liver disease]] ❑ Metabolic/genetic diseases Hereditary hemochromatosis ppWilson's disease]] ppAlpha-1 antitrypsin deficiency]] ❑ Drug-induced and supplemental-induced injury Acetaminophen, kavakava, Vinyl cholride ❑ Pregnancy AFLP,HELLP ❑ Autoimmune hepatitis ❑ Ischemic hepatitis | Bile ducts dilated | Bile ducts not dilated | ||||||||||||||||||||||||||||||||||||||||||||
ERCP/CT | Additional work-up for intrahepatic cholestasis | ||||||||||||||||||||||||||||||||||||||||||||||
❑ Common bile duct stones ❑ Biliray stricture ❑ Worms/flukes ❑ Extrahepatic sources: ❑ Cholangiocarcinoma ❑ Pancreatic cancer | Consider following based on the results: | ||||||||||||||||||||||||||||||||||||||||||||||
Treatment
Type of hyperbilirubinemia | Diagnostic Indicators | Management Recommendations |
---|---|---|
Managment of isolated unconjugated jaundice, hemolytic |
hemolysis
|
|
Managment of isolated unconjugated jaundice, Non-hemolytic |
|
|
Managment of isolated conjugated jaundice |
|
|
Managment of conjugated & unconjugated hyperbilirubinemia jaundice with ⇈AST/ALT out of proportion to ALP' |
|
|
Managment of conjugated & unconjugated hyperbilirubinemia jaundice with ⇈ AlP out of proportion to AST/ALT |
|
|
|
Do's
- Alcohol Use: Screen for alcohol use disorders in all patients
- Medications: Discuss the safety of limited (2 gram/day) acetaminophen use, review pharmacologic history, and discontinue medications that cause hemolysis or drug-induced hepatitis.
- Treat of underlying disease conditions
- Liver Transplant Referral: Refer early when a patient needs
- Palliative Care: Address goals of care and refer to palliative care early especially for patients with tumors
Don'ts
- Forget to discuss medication to avoid, especially in patients with G6PD or drug-induced hepatitis.
- Delay palliative care until the patient is in a critical state.
- Delay referring a patient to the liver transplant center until the patient is hospitalized in life-threatening condition
References
- ↑ Warner, Ben; Wilkinson, Mark (2017). "Acute jaundice": 150–154. doi:10.1002/9781119389613.ch23.
- ↑ Giannini EG, Testa R, Savarino V (February 2005). "Liver enzyme alteration: a guide for clinicians". CMAJ. 172 (3): 367–79. doi:10.1503/cmaj.1040752. PMC 545762. PMID 15684121.
- ↑ Walker HK, Hall WD, Hurst JW, Stillman AE. PMID 21250253. Missing or empty
|title=
(help) - ↑ Gondal B, Aronsohn A (December 2016). "A Systematic Approach to Patients with Jaundice". Semin Intervent Radiol. 33 (4): 253–258. doi:10.1055/s-0036-1592331. PMC 5088098. PMID 27904243.
- ↑ Syhavong B, Rasachack B, Smythe L, Rolain JM, Roque-Afonso AM, Jenjaroen K, Soukkhaserm V, Phongmany S, Phetsouvanh R, Soukkhaserm S, Thammavong T, Mayxay M, Blacksell SD, Barnes E, Parola P, Dussaix E, Raoult D, Humphreys I, Klenerman P, White NJ, Newton PN (July 2010). "The infective causes of hepatitis and jaundice amongst hospitalised patients in Vientiane, Laos". Trans. R. Soc. Trop. Med. Hyg. 104 (7): 475–83. doi:10.1016/j.trstmh.2010.03.002. PMC 2896487. PMID 20378138.